ClinicalTrials.gg
RecruitingNCT07442721Updated Mar 3, 2026

Sacral ESPB vs. PENG Block for Hip Hemiarthroplasty Analgesia

An interventional study of Sacral erector spinae plane block and PENG block in Hip Arthroplasty, Hip Fracture Surgeries and Femoral Neck Fractures, sponsored by Fayoum University Hospital. Recruiting at 1 site in Egypt. Open to participants aged 50 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-03-03.

Sponsored by Fayoum University Hospital · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
50 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Femoral Neck Fractures with a site in Egypt — 4 open to participants now, 7 under way, none of them phase 3. Femoral Neck Fractures · Egypt.

Planned enrollment
Largest of 11
80 · median 30
Started
2026
with 1 other
No phase
10 of 11
4 open now
Registered
9th of 11
by date
Lead sponsor
1 of 11
Fayoum University Hospital

Among the 11 studies in Femoral Neck Fractures with a site in Egypt, this one has the largest planned enrollment, is one of 2 that started in 2026, is one of 10 with no phase, and was the 9th registered.

Femoral Neck Fractures

207 studies on the registry are indexed under Femoral Neck Fractures; 40 are open to participants now.

Browse Femoral Neck Fractures studies →

Open to participants now

4 of the 11 studies in Femoral Neck Fractures with a site in Egypt are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 23 Femoral Neck Fractures studies recruiting now, 16 (70%) set no upper age limit and 4 (17%) stop at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.

This study: 50 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Femoral Neck Fractures with a site in Egypt, or all of them as a file.
02

Study summary

Sacral erector spinae plane block(S-ESPB) has been recently described. Case reports are showing that it is useful in various types of surgery. In case presentations, it has been reported as effective in providing analgesia in the posterior branches of the sacral nerves in pilonidal sinus surgery, in the treatment of radicular pain at the L5 - S1 level, after a sex reassignment operation and hypospadias surgery, and its use in combination with lumbar ESPB for analgesia was reported after hip prosthesis surgery . Described in 2018, pericapsular nerve group (PENG) block selectively targets the articular branches of the femoral and accessory obturator nerves thereby providing potential motorsparing analgesia for hip surgery

. Recent studies found that PENG block targets the articular branches of the femoral and accessory obturator nerves, only anesthetizes the anterior hip joint sparing posterior part , as well as there was a motor impairment after block which is from local anesthetic (LA) diffusion to the femoral nerve

. Motor-sparing regional anesthesia techniques have emerged as a safer alternative, balancing effective pain relief with the preservation of quadriceps function . These techniques align with Enhanced Recovery After Surgery (ERAS) protocols, which emphasize multimodal pain control, opioid minimization, and early mobility to reduce complications such as venous thromboembolism (VTE) and postoperative pneumonia

.

Read the detailed description

Study design This double-blinded, prospective, randomized comparative study will be conducted in Fayoum University hospital after the approval of local Institutional Ethics Committee and local institutional review board. Written informed consent will be obtained from all patients for these scientific contributions before recruitment and randomization.

Randomization, Allocation Concealment and blinding Patients will be randomly allocated into one of 2 parallel groups (40 in each group) based on sample size. Randomization will be achieved using computer-generated random numbering of each study patient. Allocation concealment will be insured using Sequentially Numbered, Opaque, Sealed Envelopes (SNOSE), prepared by a researcher not involved in patient recruitment or outcome assessment. The block tray and necessary equipment will be prepared by an independent anesthesiologist not involved in patient assessment. The patient and researcher who collects the data after the block will be blinded to the study group. All study outcomes will be evaluated by a dedicated anesthesiologist who will be blinded to the group allocation.Patients will be randomized into 2 groups.

Group (S) patients who will receive sacral erector spinae plane block. Group (G) patients who will receive pericapsular nerve group block. Anesthesia procedure

  • The study protocol, sacral erector plane block, PENG block and the numerical pain rating score (NPRS) will be explained to each patient during the preanesthetic counselling. The (NPRS) is 11-point numeric scale ranges from 0 to 10, (where score 0 =no pain and 10 =worst pain imaginable) .
  • . Before the participants will be admitted in this study, the purpose and nature of the study, as well as the risk-benefit assessment will be explained to them. An informed consent will be obtained from participants. Patients will fast for about 6 to 8 hours for solid meals, for 4 hours for non-clear liquids and for 2 hours for clear liquids before surgery .

Anesthetic technique

  • Perioperative anesthesia management will be according to our hospital routine protocol.
  • An intravenous cannula will be inserted in the hand and standard monitoring (noninvasive blood pressure, electrocardiography, and pulse oximetry) will be applied.
  • In all patients, spinal anesthesia will be performed in the sitting position. The midline at level of the L3-4 and L4-5 intervertebral spaces will be identified, and spinal anesthesia will be administered using 25-gauge Quincke needle.
  • Patients will be immediately placed in the supine position. Spinal anesthesia will be considered successful when a bilateral block to T12, as assessed by loss of cold (cold ice) and pain (a 23-gauge needle) sensations, will be established 10 minutes after the intrathecal injection, the surgery will be done using a lateral approach and a lateral decubitus position. Local Anesthetic Dose, Safety, and Emergency Preparedness

    1. Sacral ESPB: 30 mL of 0.25% bupivacaine HCl (plain), equivalent to 75 mg. PENG block: 20 mL of 0.25% bupivacaine HCl (plain), equivalent to 50 mg . Both doses fall well within the recommended maximum safe dose for elderly patients and selected per anatomical requirements and RCT evidence. The maximum safe dose of plain bupivacaine will be strictly adhered to, defined as 2 mg/kg, not exceeding an absolute maximum of 150 mg.
    2. Slow Incremental Injection: The standard practice is to inject the local anesthetic under ultrasound guidance in small boluses, commonly 5-10 mL at a time, followed by aspiration to rule out intravascular placement and systemic toxicity.
    3. Emergency preparedness measures included:

      (i) Lipid rescue protocol availability: 20% Intralipid solution will be readily available for immediate intravenous administration in the event of local anesthetic systemic toxicity (LAST), according to ASRA guidelines.

      (ii) Monitoring for LAST: Continuous monitoring of neurological status (e.g., dizziness, perioral numbness, seizures) and cardiovascular parameters (ECG, blood pressure, heart rate) will be performed throughout the procedure and during the immediate post-block period.

      (iii) Allergic/anaphylaxis management: Emergency medications (adrenaline, antihistamines, corticosteroids) and resuscitation equipment will be available, with a predefined protocol for prompt management of any hypersensitivity reactions.

      (iv)Emergency airway management equipment will be available at the bed side. (V) Stop rule will be applied if unexpected adverse events (e.g., severe hypotension, arrhythmia, LA toxicity). Postoperative analgesia protocol All patients will receive standardized multimodal analgesia. Paracetamol (1 g every 6 hours) and NSAIDs (unless contraindicated) will be administered as routine analgesics. Opioids will be used as rescue medication according to a unified protocol for both groups. This standardized regimen aims to minimize confounding and ensure that differences in pain scores are attributable to the regional techniques.

03

Conditions studied

  • Hip Arthroplasty
  • Hip Fracture Surgeries
  • Femoral Neck Fractures
  • Postoperative Pain
04

Who can participate

Ages eligible
50 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with ages from 50 to 90 years of either gender, with diagnosis of intracapsular neck of femur fracture scheduled for elective hip hemiarthroplasty • Patients with an (ASA) physical status I to III.

Exclusion criteria

Exclusion Criteria:

    • Patient refusal.

      • Allergy to local anesthetics and patient with infection at the injection site of block
      • Patient with to spinal anesthesia.
      • Coagulopathy as ≥1.5 or ≤80*103 / microliter)
      • Patients with >35 kg / m2
      • Patients with peripheral neuropathy or diabetic neuropathy
      • Patients receiving opioids for chronic analgesic therapy (cancer, addiction).
      • Cognitive impairment preventing pain scoring.
      • Chronic renal failure requiring dose modification.
      • Bilateral hip fracture or previous ipsilateral hip surgery
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

INR, PT and aPTT (clotting tests)

Blood tests of how long blood takes to clot. The INR is the prothrombin time (PT) put on a common scale; about 1 is usual for someone not taking a blood thinner.

Criteria often make an exception for people on a blood thinner such as warfarin, whose INR is raised on purpose.

Platelets

Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    S group

    This group will receive sacral erector spinae plane block in the operating room, after spinal anesthesia and before skin incision, when the patient will be in the lateral decubitus position, aseptic conditions will be provided for the block.

    Procedure: Sacral erector spinae plane block

  • Active comparator
    G group

    This group will receive PENG Block in the operating room, after spinal anesthesia and before skin incision. Patients will be placed in the supine position, aseptic conditions will be provided for the block.

    Procedure: PENG block

Interventions

  • ProcedureSacral erector spinae plane block

    the curvilinear transducer of ultrasound will be placed parallel to the median sacral crest pointing towards the caudal direction. After visualizing the S1 median sacral crest, the transducer will be shifted caudally. When the S2 level will be reached, the transducer will be moved 3-4 cm laterally. Then, the intermediate crest (IC) will be detected in the parasagittal plane. At the S2-3 level, a 22-gauge Quincke spinal needle,90 mm in length will be advanced in the caudo-cranial direction under the erector spinae muscle but superficial to the transverse process at the sacral level and achieving bone contact (at depth from 3cm to 5cm according to subcutaneous tissue thickness and muscle mass). Then local anesthetic (LA)(0.5mL/kg of bupivacaine 0.25%) will be injected following negative aspiration ensuring that total administered dose remains below toxicity threshold(150mg). The correct spread is confirmed by visualizing LA separating the erector spinae muscle from the underlying bone.

  • ProcedurePENG block

    The ultrasound transducer will be placed in a transverse orientation, medial and caudal to the anterosuperior iliac spine in order to identify the anteroinferior iliac spine, the iliopubic eminence and the psoas tendon. Using an in-plane technique and a lateral-to-medial direction, a 22-gauge Quincke spinal needle,90 mm in length will be advanced until its tip will be positioned on the periosteum dorsal to the psoas tendon (3-5cm from the skin). The local anesthetic (0.5mL/kg of bupivacaine 0.25%) will be injected following negative aspiration ensuring that total administered dose remains below toxicity threshold(150mg). The accurate position of the needle will be confirmed by hydro dissection and spread under the ilio-psoas muscle. To avoid femoral nerve involvement, and therefore quadriceps weakness ,the investigator will perform lateral needle placement (away from the undersurface of the iliopsoas tendon), also lower volume is needed, slower injection.

06

What researchers measure

Primary outcomes

  1. Numerical pain rating score (NPRS) after surgery at rest.

    Numerical Pain Rating Scale (NPRS) is a subjective measure where patients rate their pain on an 11-point numerical scale. The scale ranges from 0 to 10, where 0 represents "no pain" and 10 represents "worst possible pain." Higher scores indicate a worse outcome (greater pain intensity).

    Time frame: At twelve hours postoperatively

Secondary outcomes

  1. Numerical Pain Rating Scale(NPRS) during movement and at rest in 24 h after surgery at (2,4,6,8,12,18,24)

    NPRS (Numerical Pain Rating Scale) is assessed during movement and at rest at 2, 4, 6, 8, 12, 18, and 24 hours after surgery. The scale ranges from 0 to 10, where 0 represents "no pain" and 10 represents "worst possible pain." Higher scores indicate a worse outcome (greater pain intensity).

    Time frame: At 2, 4, 6, 8, 12, 18, and 24 hours postoperatively.

  2. Cumulative morphine consumption in 24 hours in mg

    cumulative amount of morphine in mg (will be consumed in the first 24 hours)will be measured

    Time frame: During the first 24 hours postoperatively

  3. Time for first rescue analgesia (hours), standard rescue analgesia (Morphine PCA or IV (dose specified)

    The time from the end of surgery until the first request for rescue analgesia (provided as Morphine PCA or IV) during the first 24 hours postoperatively.

    Time frame: In the first 24 hours postoperatively

  4. Intraoperative opioids consumption.

    Cumulative intraoperative opioid dose, converted to Morphine Milligram Equivalents (MME) for standardized comparison between groups, administered throughout the surgical procedure

    Time frame: Intraoperative peroid

  5. Inability to perform physiotherapy at 24 hours.

    The incidence of inability to perform the standardized physiotherapy protocol due to pain or motor block at 24 hours postoperatively .

    Time frame: At 24 hours postoperatively.

  6. Delirium assessment (CAM score), a diagnosis of delirium is made if the patient has both (Acute onset and fluctuating course) and (Inattention), plus either (Disorganized thinking) or (Altered level of f consciousness) 20

    Incidence of postoperative delirium, assessed using the Confusion Assessment Method (CAM) algorithm. A positive diagnosis requires the presence of: (1) acute onset and fluctuating course, (2) inattention, AND either (3) disorganized thinking OR (4) altered level of consciousness.

    Time frame: Twice daily (every 12 hours) for the first 72 hours postoperatively.

  7. The incidence of block-related adverse events (ie, vascular puncture, LA toxicity).

    The incidence of block-related complications, specifically accidental vascular puncture (defined as aspiration of blood during needle placement) and Local Anesthetic Systemic Toxicity (LAST) (defined by neurological or cardiovascular signs following LA injection).

    Time frame: For Vascular Puncture: "Intraoperatively, during the performance of the nerve block. For LA Toxicity (LAST): "From the time of injection until 60 minutes post-procedure.

  8. Incidence of quadriceps motor block at 3,6,12,24 hours postoperatively

    Incidence of quadriceps motor block, assessed using the Medical Research Council (MRC) scale for muscle strength (0 to 5). Motor block is defined as any reduction in strength (MRC score \< 5) during active knee extension against resistance.

    Time frame: At 3, 6, 12, and 24 hours postoperatively.

  9. Opioid related side effects (ie, nausea, vomiting, urine retention, respiratory depression)

    Incidence of opioid-induced respiratory depression (OIRD), defined as a respiratory rate \< 8-10 breaths/minute or oxygen saturation (SpO2) \< 90% for more than 1 minute, or any other related side effects like nausea, vomiting, urine retention.

    Time frame: From the time of the first dose up to 24 hours post-administration.

  10. Length of stay in hospital.

    The number of days from the date of surgery until the date of hospital discharge.

    Time frame: From the day of surgery until hospital discharge, assessed up to 30 days.

07

Study locations

1 of 1 sites recruiting
  • Fayoum University hospita
    El Fayoum Qesm, Faiyum Governorate 63514, Egypt
    Recruiting
08

References and documents

Publications

  • Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990 Dec 15;113(12):941-8. doi: 10.7326/0003-4819-113-12-941. PubMed 2240918 ↗
  • Johnson C. Measuring Pain. Visual Analog Scale Versus Numeric Pain Scale: What is the Difference? J Chiropr Med. 2005 Winter;4(1):43-4. doi: 10.1016/S0899-3467(07)60112-8. PubMed 19674646 ↗
  • Childs JD, Piva SR, Fritz JM. Responsiveness of the numeric pain rating scale in patients with low back pain. Spine (Phila Pa 1976). 2005 Jun 1;30(11):1331-4. doi: 10.1097/01.brs.0000164099.92112.29. PubMed 15928561 ↗
  • Studzinska D, Pabjanczyk I, Polok K, Szczeklik W. Perioperative utilization of tranexamic acid in total knee and hip arthroplasty procedures in Poland - a survey-based study. Anaesthesiol Intensive Ther. 2024;56(3):206-207. doi: 10.5114/ait.2024.142670. No abstract available. PubMed 39451168 ↗
  • Kutnik P, Bierut M, Rypulak E, Trwoga A, Wroblewska K, Marzeda P, Kosmider K, Kamieniak M, Pajak A, Wolanin N, Gebska-Wolinska M, Borys M. The use of the ERAS protocol in malnourished and properly nourished patients undergoing elective surgery: a questionnaire study. Anaesthesiol Intensive Ther. 2023;55(5):330-334. doi: 10.5114/ait.2023.134190. PubMed 38282499 ↗
  • Lavand'homme PM, Kehlet H, Rawal N, Joshi GP; PROSPECT Working Group of the European Society of Regional Anaesthesia and Pain Therapy (ESRA). Pain management after total knee arthroplasty: PROcedure SPEcific Postoperative Pain ManagemenT recommendations. Eur J Anaesthesiol. 2022 Sep 1;39(9):743-757. doi: 10.1097/EJA.0000000000001691. Epub 2022 Jul 20. PubMed 35852550 ↗
  • Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018 Jun;27(6):1785-1805. doi: 10.1177/0962280216669183. Epub 2016 Sep 27. PubMed 27683581 ↗
  • Aliste J, Layera S, Bravo D, Jara A, Munoz G, Barrientos C, Wulf R, Branez J, Finlayson RJ, Tran Q. Randomized comparison between pericapsular nerve group (PENG) block and suprainguinal fascia iliaca block for total hip arthroplasty. Reg Anesth Pain Med. 2021 Oct;46(10):874-878. doi: 10.1136/rapm-2021-102997. Epub 2021 Jul 20. PubMed 34290085 ↗
  • Giron-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847. PubMed 30063657 ↗
  • Senthil KS, Kumar P, Ramakrishnan L. Comparison of Pericapsular Nerve Group Block versus Fascia Iliaca Compartment Block as Postoperative Pain Management in Hip Fracture Surgeries. Anesth Essays Res. 2021 Oct-Dec;15(4):352-356. doi: 10.4103/aer.aer_119_21. Epub 2022 Mar 1. PubMed 35422548 ↗
  • Birnbaum K, Prescher A, Hessler S, Heller KD. The sensory innervation of the hip joint--an anatomical study. Surg Radiol Anat. 1997;19(6):371-5. doi: 10.1007/BF01628504. PubMed 9479711 ↗
  • Aksu C, Gurkan Y. Sacral Erector Spinae Plane Block with longitudinal midline approach: Could it be the new era for pediatric postoperative analgesia? J Clin Anesth. 2020 Feb;59:38-39. doi: 10.1016/j.jclinane.2019.06.007. Epub 2019 Jun 13. No abstract available. PubMed 31203111 ↗
  • Kilicaslan A, Uyel Y. Novel lumbosacral approach for erector spinae plane block (LS-ESPB) in hip surgery. J Clin Anesth. 2020 Mar;60:83-84. doi: 10.1016/j.jclinane.2019.08.040. Epub 2019 Aug 30. No abstract available. PubMed 31476627 ↗
  • Kukreja P, Deichmann P, Selph JP, Hebbard J, Kalagara H. Sacral Erector Spinae Plane Block for Gender Reassignment Surgery. Cureus. 2020 Apr 14;12(4):e7665. doi: 10.7759/cureus.7665. PubMed 32419993 ↗
  • Piraccini E, Antioco M, Maitan S. Ultrasound guided sacral erector spinae plane block: A useful tool for radicular pain treatment. J Clin Anesth. 2020 Feb;59:11-12. doi: 10.1016/j.jclinane.2019.06.011. Epub 2019 Jun 6. No abstract available. PubMed 31176955 ↗
  • Tulgar S, Senturk O, Thomas DT, Deveci U, Ozer Z. A new technique for sensory blockage of posterior branches of sacral nerves: Ultrasound guided sacral erector spinae plane block. J Clin Anesth. 2019 Nov;57:129-130. doi: 10.1016/j.jclinane.2019.04.014. Epub 2019 Apr 15. No abstract available. PubMed 30999197 ↗
  • Gerhardt M, Johnson K, Atkinson R, Snow B, Shaw C, Brown A, Vangsness CT Jr. Characterisation and classification of the neural anatomy in the human hip joint. Hip Int. 2012 Jan-Feb;22(1):75-81. doi: 10.5301/HIP.2012.9042. PubMed 22344482 ↗
  • Langworthy MJ, Sanzone AG. Multimodal Pain Strategies Including Liposomal Bupivacaine for Isolated Acetabular Fracture Surgery. J Orthop Trauma. 2018 Aug;32 Suppl 2:S11-S15. doi: 10.1097/BOT.0000000000001228. PubMed 30028759 ↗
  • Natrajan P, Bhat RR, Remadevi R, Joseph IR, Vijayalakshmi S, Paulose TD. Comparative Study to Evaluate the Effect of Ultrasound-Guided Pericapsular Nerve Group Block Versus Fascia Iliaca Compartment Block on the Postoperative Analgesic Effect in Patients Undergoing Surgeries for Hip Fracture under Spinal Anesthesia. Anesth Essays Res. 2021 Jul-Sep;15(3):285-289. doi: 10.4103/aer.aer_122_21. Epub 2022 Feb 7. PubMed 35320956 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Jul 2027, 17 months after the start.

Of 63 non-industry interventional studies with no phase under Femoral Neck Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 62. This study's planned 17 months is below that.

Counting every sponsor, half of 69 studies reached it within 46 months; a quarter within 25 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 19, 2026
First posted
Mar 2, 2026
StartActual
Feb 1, 2026
Primary completionEst.
Jul 1, 2027
CompletionEst.
Aug 1, 2027
Last update
Mar 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07442721
Lead sponsor
Fayoum University Hospital
Responsible party
Mohamed Ahmed Hamed (professor of anesthesia, Surgical ICU and Pain management , Faculty of Medicine, Fayoum University, Fayoum University Hospital) — Principal investigator
First posted
Mar 2, 2026
Start date
Feb 1, 2026
Primary completion
Jul 1, 2027 (estimated)
Completion
Aug 1, 2027 (estimated)
Last update
Mar 3, 2026

Study contacts

Samar Ahmed Ramadan
Contact
sar15@fayoum.edu.eg
01028384348
Mohamed Ahmed Hamed
Contact
mah07@fayoum.edu.eg
01010509736

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion